ATA207275A - Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung - Google Patents

Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung

Info

Publication number
ATA207275A
ATA207275A AT207275A AT207275A ATA207275A AT A207275 A ATA207275 A AT A207275A AT 207275 A AT207275 A AT 207275A AT 207275 A AT207275 A AT 207275A AT A207275 A ATA207275 A AT A207275A
Authority
AT
Austria
Prior art keywords
preparation
pharmaceutical composition
effective pharmaceutical
antivirally effective
antivirally
Prior art date
Application number
AT207275A
Other languages
English (en)
Other versions
AT343276B (de
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ATA207275A publication Critical patent/ATA207275A/de
Application granted granted Critical
Publication of AT343276B publication Critical patent/AT343276B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT207275A 1975-02-13 1975-03-18 Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung AT343276B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6173/75A GB1530912A (en) 1975-02-13 1975-02-13 Compositions containing 9-(2-hydroxy-3-alkyl)-adenines

Publications (2)

Publication Number Publication Date
ATA207275A true ATA207275A (de) 1977-09-15
AT343276B AT343276B (de) 1978-05-26

Family

ID=9809759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT207275A AT343276B (de) 1975-02-13 1975-03-18 Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung

Country Status (10)

Country Link
US (1) US4315920A (de)
AT (1) AT343276B (de)
BE (1) BE826935A (de)
CA (1) CA1054521A (de)
DE (1) DE2512609A1 (de)
GB (1) GB1530912A (de)
IN (1) IN141900B (de)
NZ (1) NZ176971A (de)
ZA (1) ZA751650B (de)
ZM (1) ZM5975A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
DE3323621A1 (de) * 1982-07-08 1984-03-01 Yamasa Shoyu K.K., Choshi, Chiba Pharmazeutisches praeparat mit die antitumor-wirkung verstaerkender wirkung, ein solches praeparat enthaltende chemotherapeutische zusammensetzung und verwendung des praeparates zur unterstuetzung der antitumor-behandlung beim menschen und tier
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
CA2199615A1 (en) * 1996-02-12 1997-08-14 Elie Abushanab Erythro-hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemia traits
WO1999057120A1 (en) 1998-05-04 1999-11-11 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6579857B1 (en) * 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
AU2001271908A1 (en) 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives

Also Published As

Publication number Publication date
DE2512609A1 (de) 1976-08-26
GB1530912A (en) 1978-11-01
BE826935A (fr) 1975-09-22
NZ176971A (en) 1984-07-31
CA1054521A (en) 1979-05-15
ZM5975A1 (en) 1977-01-21
AT343276B (de) 1978-05-26
ZA751650B (en) 1976-10-27
US4315920A (en) 1982-02-16
AU7934275A (en) 1976-09-23
IN141900B (de) 1977-04-30

Similar Documents

Publication Publication Date Title
DD128812A5 (de) Verfahren zur herstellung von chinazolonderivaten
DD133803A1 (de) Verfahren zur herstellung von furokumarinen
DD128782A5 (de) Verfahren zur herstellung von n-alkyldiphenylaminen
ATA207275A (de) Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung
DD134090A5 (de) Verfahren zur herstellung von pyridinylaminoalkylaether
AT351187B (de) Verfahren zur herstellung von 7-dehydrochol- esterinderivaten
AT344147B (de) Verfahren zur herstellung von acylcyaniden
AT348123B (de) Verfahren zur herstellung von antibakteriellen aminoglycosidderivaten
DD130576A5 (de) Verfahren zur herstellung von derivaten von 5-hydroxy-chininzarinchinon
ATA314576A (de) Verfahren zur herstellung von 4-nideralkyl-5- cyano-oxazolen
LU79591A1 (de) Verfahren zur herstellung von benzimidazol-derivaten
ATA392577A (de) Verfahren zur herstellung von acylcyaniden
AT349032B (de) Verfahren zur herstellung von 4-alkyl-thiosemicarbaziden
DD132435A5 (de) Verfahren zur herstellung von indolochinolizinen
ATA392477A (de) Verfahren zur herstellung von acylcyaniden
DD130144A5 (de) Verfahren zur herstellung von benzoylcyanid
ATA55178A (de) Verfahren zur herstellung von 1alpha-hydroxy- -cholesterin-derivaten
DD134100A5 (de) Verfahren zur herstellung von lactamen
LU78483A1 (de) Verfahren zur herstellung von benzoxazolyl-phenylstilbenen
DD139252A5 (de) Verfahren zur herstellung von alkylphenolen
LU78135A1 (de) Verfahren zur herstellung von benzodifuranen
DD135382A5 (de) Verfahren zur herstellung von triazolo-thieno-diazepin-1-onen
DD122977A5 (de) Verfahren zur herstellung von thieno-pyridin-derivaten
DD127949A5 (de) Verfahren zur herstellung von cephalosporinen
DD134083A5 (de) Verfahren zur herstellung von malonsaeurederivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties